Grupo de Investigación en Fisiopatología Cardiovascular
CTS237
Hospital Arnau de Vilanova
Valencia, EspañaPublicacions en col·laboració amb investigadors/es de Hospital Arnau de Vilanova (4)
2019
-
Comparison of seven prognostic tools to identify low-risk pulmonary embolism in patients aged <50 years
Scientific Reports, Vol. 9, Núm. 1
2005
-
Phase II study of a fixed dose-rate infusion of gemcitabine associated with docetaxel in advanced non-small-cell lung carcinoma
Cancer Chemotherapy and Pharmacology, Vol. 55, Núm. 2, pp. 197-202
2004
-
Biweekly docetaxel and vinorelbine as first-line chemotherapy in metastatic breast cancer
Clinical Breast Cancer, Vol. 5, Núm. 2, pp. 131-135
-
Docetaxel plus epirubicin is a highly active, well-tolerated, first-line chemotherapy for metastatic breast cancer: Results of a large, multicentre phase II study
Cancer Chemotherapy and Pharmacology, Vol. 53, Núm. 1, pp. 75-81